The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1072
ISSUE 1072
February 21, 2000
Issue 1072
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Gatifloxacin and Moxifloxacin: Two New Fluoroquinolones
February 21, 2000 (Issue: 1072)
Gatifloxacin and moxifloxacin are now available for once-daily treatment of patients with community-acquired pneumonia, acute bacterial exacerbations of chronic bronchitis, or acute sinusitis.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.